耐抗生素肺炎链球菌所致感染的管理
Management of infections due to antibiotic-resistant Streptococcus pneumoniae.
作者信息
Kaplan S L, Mason E O
机构信息
Section of Pediatric Infectious Diseases, Department of Pediatrics, Baylor College of Medicine, Houston, Texas 77030, USA.
出版信息
Clin Microbiol Rev. 1998 Oct;11(4):628-44. doi: 10.1128/CMR.11.4.628.
Abstract
Antibiotic-resistant strains of Streptococcus pneumoniae are becoming more prevalent throughout the world; this has resulted in modifications of treatment approaches. Management of bacterial meningitis has the greatest consensus. Strategies for treating other systemic infections such as pneumonia, bacteremia, and musculoskeletal infections are evolving, in part related to the availability of new antibiotics which are active in vitro against isolates resistant to penicillin and the extended-spectrum cephalosporins. However, there are currently very limited data related to the clinical efficacy of these new agents. The studies upon which current recommendations are based are reviewed. Otitis media represents the single most common infection due to S. pneumoniae. Recommendations for treatment of acute otitis media due to drug-resistant strains and the rationale for these recommendations are discussed.
摘要
肺炎链球菌的耐药菌株在全球范围内正变得越来越普遍；这导致了治疗方法的改变。细菌性脑膜炎的管理具有最大的共识。治疗其他全身感染（如肺炎、菌血症和肌肉骨骼感染）的策略正在不断发展，部分原因是有了对体外对青霉素和广谱头孢菌素耐药的分离株有效的新抗生素。然而，目前关于这些新药物临床疗效的数据非常有限。对当前建议所依据的研究进行了综述。中耳炎是由肺炎链球菌引起的最常见的单一感染。讨论了耐药菌株引起的急性中耳炎的治疗建议及其依据。
相似文献
1
Management of infections due to antibiotic-resistant Streptococcus pneumoniae.
Clin Microbiol Rev. 1998 Oct;11(4):628-44. doi: 10.1128/CMR.11.4.628.
2
Management of infections caused by antibiotic-resistant Streptococcus pneumoniae.
N Engl J Med. 1994 Aug 11;331(6):377-82. doi: 10.1056/NEJM199408113310607.
3
Pneumococcal infection in children: rational antibiotic choice for drug-resistant Streptococcus pneumoniae.
Acta Paediatr Taiwan. 2003 Mar-Apr;44(2):67-74.
4
Drug-resistant Streptococcus pneumoniae: rational antibiotic choices.
Am J Med. 1999 May 3;106(5A):19S-25S; discussion 48S-52S. doi: 10.1016/s0002-9343(98)00351-9.
5
Streptococcus pneumoniae as an agent of nosocomial infection: treatment in the era of penicillin-resistant strains.
Clin Microbiol Infect. 2001;7 Suppl 4:34-42. doi: 10.1046/j.1469-0691.2001.00056.x.
6
Clinical relevance of penicillin-resistant Streptococcus pneumoniae.
Semin Respir Infect. 2002 Sep;17(3):204-14. doi: 10.1053/srin.2002.34686.
7
Antibiotic management of pneumococcal infections in an era of increased resistance.
J Paediatr Child Health. 1997 Aug;33(4):287-95. doi: 10.1111/j.1440-1754.1997.tb01602.x.
8
Antibiotic-resistant pneumococci in pediatric disease.
Microb Drug Resist. 1995 Spring;1(1):5-8. doi: 10.1089/mdr.1995.1.5.
9
Antibiotic resistance of Streptococcus pneumoniae in children with acute otitis media treatment failure.
Int J Pediatr Otorhinolaryngol. 2015 Dec;79(12):2129-33. doi: 10.1016/j.ijporl.2015.09.030. Epub 2015 Sep 30.
10
Incidence of antibiotic-resistant Streptococcus pneumoniae and beta-lactamase-positive Haemophilus influenzae in clinical isolates from patients with otitis media.
Pediatr Infect Dis J. 1996 Sep;15(9 Suppl):S3-9. doi: 10.1097/00006454-199609009-00001.
引用本文的文献
1
Molecular Profile and the Effectiveness of Antimicrobials Drugs Against and in the Diagnostic Approaches of Otitis Infection.
Infect Drug Resist. 2023 Jul 5;16:4397-4408. doi: 10.2147/IDR.S418685. eCollection 2023.
2
Antibiotic resistance pattern, capsular types, and molecular characterization of invasive isolates of Streptococcus pneumoniae in the south of Tunisia from 2012 to 2018.
BMC Microbiol. 2023 Feb 4;23(1):36. doi: 10.1186/s12866-023-02784-2.
3
activity of lactone ketolide nafithromycin (WCK 4873) against isolates enriched with macrolide-resistance phenotype collected from mainland China.
JAC Antimicrob Resist. 2022 Oct 10;4(5):dlac103. doi: 10.1093/jacamr/dlac103. eCollection 2022 Oct.
4
Examining the Efficacy of Antimicrobial Therapy in Preventing the Development of Postinfectious Glomerulonephritis: A Systematic Review and Meta-Analysis.
Infect Dis Rep. 2022 Mar 7;14(2):176-183. doi: 10.3390/idr14020022.
5
Antifungal and Larvicidal Activities of Phlorotannins from Brown Seaweeds.
Mar Drugs. 2021 Apr 16;19(4):223. doi: 10.3390/md19040223.
6
Upregulation of Glutamate Transporter 1 by Clavulanic Acid Administration and Attenuation of Allodynia and Hyperalgesia in Neuropathic Rats.
Basic Clin Neurosci. 2019 Jul-Aug;10(4):345-354. doi: 10.32598/bcn.10.4.799.2. Epub 2019 Jul 1.
7
Emergence of Ceftriaxone Resistance during a Case of Pneumococcal Meningitis with Fatal Evolution.
Antimicrob Agents Chemother. 2020 Feb 21;64(3). doi: 10.1128/AAC.01958-19.
8
Pneumonia and Streptococcus pneumoniae vaccine.
Arch Pharm Res. 2017 Aug;40(8):885-893. doi: 10.1007/s12272-017-0933-y. Epub 2017 Jul 22.
9
In silico study on Penicillin derivatives and Cephalosporins for upper respiratory tract bacterial pathogens.
3 Biotech. 2014 Jun;4(3):241-251. doi: 10.1007/s13205-013-0147-z. Epub 2013 Jun 11.
10
Differences in antibiotic-induced oxidative stress responses between laboratory and clinical isolates of Streptococcus pneumoniae.
Antimicrob Agents Chemother. 2015 Sep;59(9):5420-6. doi: 10.1128/AAC.00316-15. Epub 2015 Jun 22.
本文引用的文献
1
Clinical characteristics and outcome of children with pneumonia attributable to penicillin-susceptible and penicillin-nonsusceptible Streptococcus pneumoniae.
Pediatrics. 1998 Dec;102(6):1369-75. doi: 10.1542/peds.102.6.1369.
2
Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use.
Pediatrics. 1998 Nov;102(5):1087-97. doi: 10.1542/peds.102.5.1087.
3
Three-year multicenter surveillance of systemic pneumococcal infections in children.
Pediatrics. 1998 Sep;102(3 Pt 1):538-45. doi: 10.1542/peds.102.3.538.
4
Pyogenic bacterial pneumonia in human immunodeficiency virus-infected inpatients: a clinical, radiological, microbiological, and epidemiological study.
Clin Infect Dis. 1998 Apr;26(4):964-71. doi: 10.1086/513944.
5
Community-acquired pneumonia in adults: guidelines for management. The Infectious Diseases Society of America.
Clin Infect Dis. 1998 Apr;26(4):811-38. doi: 10.1086/513953.
6
Comparative in vitro killing activities of meropenem, imipenem, ceftriaxone, and ceftriaxone plus vancomycin at clinically achievable cerebrospinal fluid concentrations against penicillin-resistant Streptococcus pneumoniae isolates from children with meningitis.
Antimicrob Agents Chemother. 1998 Apr;42(4):942-4. doi: 10.1128/AAC.42.4.942.
7
Penetration of ceftriaxone into the middle ear fluid of children.
Pediatr Infect Dis J. 1998 Mar;17(3):258-60. doi: 10.1097/00006454-199803000-00022.
8
Amoxicillin middle ear fluid penetration and pharmacokinetics in children with acute otitis media.
Pediatr Infect Dis J. 1998 Feb;17(2):149-56. doi: 10.1097/00006454-199802000-00014.
9
Complicated parapneumonic effusions in children caused by penicillin-nonsusceptible Streptococcus pneumoniae.
Pediatrics. 1998 Mar;101(3 Pt 1):388-92. doi: 10.1542/peds.101.3.388.
10
Breakthrough bacteremia and meningitis during treatment with cephalosporins parenterally for pneumococcal pneumonia.
J Pediatr. 1998 Jan;132(1):174-6. doi: 10.1016/s0022-3476(98)70510-4.
Zotero 插件